Middle East Pharmaceutical Industries Company (TADAWUL:4016)
Saudi Arabia · Delayed Price · Currency is SAR 59.00
+1.15 (1.99%)
May 21, 2026, 3:19 PM AST
TADAWUL:4016 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 104.51 | 97.01 | 79.85 | 65.83 | 59.45 | 66.28 |
Depreciation & Amortization | 12.87 | 12.22 | 9.8 | 7.61 | 6.84 | 6.7 |
Other Amortization | 7.78 | 7.78 | 6.04 | 4.32 | 3.78 | 2.87 |
Loss (Gain) From Sale of Assets | -0.1 | -0.04 | -0.12 | -0.13 | -0.08 | 0.03 |
Asset Writedown & Restructuring Costs | 0.07 | 0.07 | - | 0.45 | 0.06 | - |
Loss (Gain) From Sale of Investments | - | - | - | - | - | 2.76 |
Provision & Write-off of Bad Debts | 3.48 | 1.47 | 3.54 | -1.51 | 0.13 | - |
Other Operating Activities | 3.48 | 4.32 | 10.57 | 5.77 | 7.91 | -0.88 |
Change in Accounts Receivable | -67.55 | -40.82 | -57.66 | -5.17 | 12.66 | -54.5 |
Change in Inventory | -1.32 | -7.22 | -11.7 | 12.45 | -27.38 | 8.19 |
Change in Accounts Payable | 7.77 | 16.67 | -1.03 | -9.91 | 5.22 | 6.53 |
Change in Other Net Operating Assets | 5.64 | -2.93 | -6.22 | 12.95 | -0.03 | 2.74 |
Operating Cash Flow | 76.64 | 88.54 | 33.08 | 92.66 | 68.57 | 40.72 |
Operating Cash Flow Growth | 204.58% | 167.68% | -64.30% | 35.14% | 68.40% | -8.33% |
Capital Expenditures | -23.31 | -14.79 | -11.17 | -20.83 | -9.58 | -15.43 |
Sale of Property, Plant & Equipment | 0.04 | 0.04 | 0.14 | 0.14 | 0.41 | 0.04 |
Sale (Purchase) of Intangibles | -19.79 | -19.62 | -9.78 | -10.14 | -11.03 | -9.25 |
Investment in Securities | - | - | 0.77 | - | - | -0.17 |
Investing Cash Flow | -43.05 | -34.38 | -20.04 | -30.83 | -20.2 | -24.8 |
Short-Term Debt Issued | - | 42.39 | 87.19 | 174.13 | 121.94 | - |
Long-Term Debt Issued | - | 26.14 | - | - | - | 83.52 |
Total Debt Issued | 102.69 | 68.53 | 87.19 | 174.13 | 121.94 | 83.52 |
Short-Term Debt Repaid | - | -65.09 | -77.38 | -192.99 | -119.25 | - |
Long-Term Debt Repaid | - | -3.48 | -6.34 | -6.34 | -4.75 | -59.13 |
Total Debt Repaid | -80.26 | -68.56 | -83.72 | -199.33 | -124 | -59.13 |
Net Debt Issued (Repaid) | 22.43 | -0.03 | 3.48 | -25.2 | -2.06 | 24.38 |
Common Dividends Paid | -73.38 | -46.98 | -15 | -36 | -36.35 | -37.2 |
Other Financing Activities | -3.11 | -3.22 | 6.02 | -9.31 | -5.2 | - |
Financing Cash Flow | -54.06 | -50.23 | -5.5 | -70.51 | -43.61 | -12.82 |
Miscellaneous Cash Flow Adjustments | - | - | -0.02 | - | - | 0.01 |
Net Cash Flow | -20.46 | 3.93 | 7.52 | -8.68 | 4.76 | 3.11 |
Free Cash Flow | 53.34 | 73.74 | 21.91 | 71.82 | 58.99 | 25.28 |
Free Cash Flow Growth | 272.56% | 236.62% | -69.50% | 21.76% | 133.30% | 121.46% |
Free Cash Flow Margin | 10.81% | 16.01% | 5.56% | 21.22% | 19.49% | 8.80% |
Free Cash Flow Per Share | 1.52 | 2.11 | 0.63 | 2.05 | 1.69 | 0.72 |
Cash Interest Paid | 3.22 | 3.22 | 1.46 | 4.33 | 3.93 | - |
Levered Free Cash Flow | 0.07 | 23.27 | -5.47 | 29.26 | 22.98 | -6.24 |
Unlevered Free Cash Flow | 2.24 | 25.3 | -3.17 | 32.86 | 25.94 | -5.08 |
Change in Working Capital | -55.46 | -34.29 | -76.6 | 10.31 | -9.53 | -37.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.